PetVivo Holdings, Inc. Announces Scheduled Presentations by PetVivo Veterinarians at the American Association of Equine Practitioners Convention in San Diego, California
02 November 2023 - 11:00PM
PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or
“PetVivo") an emerging biomedical device company focused on the
commercialization of innovative medical devices and therapeutics
for companion animals announced today that two members of PetVivo’s
Scientific/Veterinarian Team, Tom Yarbrough, DVM, ACVS and Joseph
Manning, DVM, MBA, will present at the American Association of
Equine Practitioners (“AAEP”) annual convention to be held November
30th to December 2nd, 2023 at the San Diego Convention Center in
San Diego, California.
Tom Yarbrough, DVM, ACVS, the Director of
Product Research for PetVivo Holdings Inc., is providing a
presentation entitled “Modern Wild West: Navigating the new classes
of joint therapeutics”. In addition, Joseph Manning, DVM, MBA,
Senior Technical Veterinarian for PetVivo Holdings, inc., will be
discussing the use of Spryng™ with OsteoCushion™ Technology in a
presentation entitled “Advancements in Intra-Articular Therapies:
Experiences with a novel collagen-elastin hydrogel microparticles
(CEHM) biomaterial used intra-articularly for joint conditions in
equines”. If you would like to attend the presentations by Dr.
Yarbrough and Dr. Manning the details are provided below.
PetVivo’s innovative product, SPRYNG™ with
OsteoCushion™ Technology, is an intra-articular injectable
veterinary medical device consisting of sterilized, extra-cellular
matrix microparticles; Spryng microparticles perform in the joint
as wet, slippery micro-cushions used in the management of lameness
and other joint related afflictions, such as osteoarthritis.
“We are incredibly honored to have two members
of our Scientific/Veterinarian Team presenting at one of the
premier conventions for equine veterinarians in the world,” said
John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “We
welcome the opportunity to support the AAEP, as well as the chance
to share the knowledge of two of our incredibly talented
veterinarians, Tom Yarbrough and Joe Manning.”
Dr. Thomas Yarbrough Presentation
Schedule:
Presentation Title: Modern Wild West: Navigating
the new classes of joint therapeutics
Presentation Date: Friday, December 1: 11:00
a.m. - 11:30 a.m.
Location for Presentation 1: San Diego
Convention Center: Theater 2
Dr. Joseph Manning Presentation
Schedule:
Presentation Title: Advancements in
Intra-Articular Therapies: Experiences with a novel
collagen-elastin hydrogel microparticles (CEHM) biomaterial used
intra-articularly for joint conditions in equines
Presentation Date: Thursday, November 30: 11:00
a.m. - 11:30 a.m.
Location for Presentation 2: San Diego
Convention Center: Theater 2
For more information about PetVivo Holdings,
Inc. and its innovative product, Spryng, please contact
info1@petvivo.com or visit https://petvivo.com/ and
https://sprynghealth.com/.
About PetVivo Holdings,
Inc.
PetVivo Holdings Inc. (NASDAQ: PETV & PETVW)
is an emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a robust pipeline of products for
the treatment of animals and people. A portfolio of twenty patents
protects the Company's biomaterials, products, production processes
and methods of use. The Company’s lead product SPRYNG™ with
OsteoCushion™ technology, a veterinarian-administered,
intraarticular injection for the management of lameness and other
joint related afflictions, including osteoarthritis, in dogs and
horses, is currently available for commercial sale.
For more information about PetVivo Holdings,
Inc. and our revolutionary product, Spryng with OsteoCushion
Technology, please contact info1@petvivo.com or visit
https://petvivo.com/ or http://sprynghealth.com.
CONTACT:
John Lai, CEO PetVivo Holdings, Inc. Email:
info1@petvivo.com (952) 405-6216
Forward-Looking Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements are
based on information currently available to the Company and its
current plans or expectations and are subject to a number of
uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2023 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
PetVivo (NASDAQ:PETVW)
Historical Stock Chart
From Apr 2024 to May 2024
PetVivo (NASDAQ:PETVW)
Historical Stock Chart
From May 2023 to May 2024